Jeff Johnson
Stock Analyst at Baird
(4.67)
# 174
Out of 4,955 analysts
145
Total ratings
59.18%
Success rate
30.31%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Maintains: Neutral | $15 → $17 | $15.89 | +6.99% | 2 | Jul 30, 2025 | |
| HSIC Henry Schein | Downgrades: Neutral | $82 → $72 | $68.48 | +5.14% | 10 | Jul 14, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $107 → $97 | $73.50 | +31.97% | 17 | May 30, 2025 | |
| NVST Envista Holdings | Upgrades: Outperform | $21 → $23 | $20.66 | +11.33% | 10 | May 27, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $130 → $115 | $105.37 | +9.14% | 14 | May 6, 2025 | |
| DXCM DexCom | Maintains: Outperform | $115 → $105 | $81.55 | +28.76% | 14 | May 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $33 → $24 | $11.13 | +115.63% | 16 | May 1, 2025 | |
| ALC Alcon | Maintains: Outperform | $104 → $108 | $79.28 | +36.23% | 9 | Feb 27, 2025 | |
| SYK Stryker | Maintains: Outperform | $378 → $405 | $389.15 | +4.07% | 11 | Oct 30, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $325 → $276 | $142.14 | +94.17% | 18 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $180 → $238 | $331.74 | -28.26% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $70 | $29.98 | +133.49% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $53 → $61 | $14.21 | +329.28% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $67 | $14.04 | +377.21% | 6 | Feb 18, 2022 |
Beta Bionics
Jul 30, 2025
Maintains: Neutral
Price Target: $15 → $17
Current: $15.89
Upside: +6.99%
Henry Schein
Jul 14, 2025
Downgrades: Neutral
Price Target: $82 → $72
Current: $68.48
Upside: +5.14%
The Cooper Companies
May 30, 2025
Maintains: Outperform
Price Target: $107 → $97
Current: $73.50
Upside: +31.97%
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21 → $23
Current: $20.66
Upside: +11.33%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $130 → $115
Current: $105.37
Upside: +9.14%
DexCom
May 2, 2025
Maintains: Outperform
Price Target: $115 → $105
Current: $81.55
Upside: +28.76%
Tandem Diabetes Care
May 1, 2025
Maintains: Neutral
Price Target: $33 → $24
Current: $11.13
Upside: +115.63%
Alcon
Feb 27, 2025
Maintains: Outperform
Price Target: $104 → $108
Current: $79.28
Upside: +36.23%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378 → $405
Current: $389.15
Upside: +4.07%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325 → $276
Current: $142.14
Upside: +94.17%
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $331.74
Upside: -28.26%
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $29.98
Upside: +133.49%
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $14.21
Upside: +329.28%
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $14.04
Upside: +377.21%